SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-17-281903
Filing Date
2017-09-11
Accepted
2017-09-11 16:54:46
Documents
5
Effectiveness Date
2017-09-11

Document Format Files

Seq Description Document Type Size
1 S-8 POS d453065ds8pos.htm S-8 POS 63641
2 EX-4.1 d453065dex41.htm EX-4.1 74433
3 EX-4.2 d453065dex42.htm EX-4.2 57846
4 EX-23.1 d453065dex231.htm EX-23.1 1974
5 EX-23.2 d453065dex232.htm EX-23.2 1974
  Complete submission text file 0001193125-17-281903.txt   201075
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-218134 | Film No.: 171079429
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1